UNSPSC 51263300: Adrenergic blocking agents, synthesized
Class
Code facts
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
Codes under 51263300
Show all 15
NIGP codes for 51263300
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes Adrenergic blocking agents composed of multiple constituents, with no dominant constituent.
About UNSPSC 51263300
UNSPSC 51263300 Adrenergic blocking agents, synthesized (Class) covers pharmaceutical products with therapeutic applications in state and local procurement, though recent activity shows a narrow mismatch between the code's nominal scope and actual buying patterns. The source reveals solicitations for naloxone (an opioid antagonist, not an adrenergic blocking agent) and pharmacy benefit program logistics rather than the synthetic adrenergic blockers the code nominally describes. State and local health agencies, particularly county health departments and state health and human services commissions, are the primary issuing bodies under this code. Work being solicited ranges from purchase of finished naloxone units for community health distribution to strategic planning around direct-to-manufacturer pharmaceutical supply relationships that bypass traditional pharmacy benefit managers and group purchasing organizations.
Recent activity centers in Florida and Texas. Seminole County, Florida posted an IFB (IFB60459723LAS) in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the county community health building, responding by July 26, 2023. The Texas Health and Human Services Commission issued an RFI (HHS0017013) in April 2026 to gather vendor capabilities around direct-to-manufacturer prescription fulfillment for its Therapeutic Pharmacy Initiative, seeking information on vendors' experience with self-insured health plans and outcomes-based contracting models. The code shows limited recent opportunity volume, and the divergence between the code's pharmaceutical category label and the actual procurement focus—naloxone distribution and pharmacy supply-chain restructuring rather than adrenergic agents—suggests that buyers may be applying the code as a catchall for pharmaceutical procurement rather than as a precise taxonomy match.
Quick answers
What is UNSPSC 51263300?
UNSPSC 51263300 is Adrenergic blocking agents, synthesized, a class in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
What codes are under UNSPSC 51263300?
UNSPSC 51263300 has 15 codes under it with their own GovTribe pages, including 51263301 Nafetolol, 51263302 Butamoxane and 51263303 Butidrine.
Which NIGP codes match UNSPSC 51263300?
UNSPSC 51263300 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51263300
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code